Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
Nicky Daniëls, Matthijs Moerkerke, Jean Steyaert, et al.
Molecular Autism (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Chronic oxytocin administration stimulates the oxytocinergic system in children with autism
Matthijs Moerkerke, Nicky Daniëls, Laura Tibermont, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
The effects of oxytocin administration on social and routinized behaviors in autism: A preregistered systematic review and meta-analysis
Kristin Audunsdottir, Alina M. Sartorius, Heemin Kang, et al.
Psychoneuroendocrinology (2024) Vol. 167, pp. 107067-107067
Open Access | Times Cited: 11
How does oxytocin modulate human behavior?
Shuxia Yao, Keith M. Kendrick
Molecular Psychiatry (2025)
Closed Access | Times Cited: 1
Toward effective oxytocin interventions in autism: Overcoming challenges and harnessing opportunities
Grazia Ricchiuti, Elise Tuerlinckx, A. Taillieu, et al.
Journal of Psychopharmacology (2025)
Closed Access | Times Cited: 1
Cannabinoid treatment for the symptoms of autism spectrum disorder
Adi Aran, Dalit Cayam Rand
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 65-79
Closed Access | Times Cited: 6
Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial
Matthijs Moerkerke, Nicky Daniëls, Stephanie Van der Donck, et al.
Journal of Child Psychology and Psychiatry (2023) Vol. 64, Iss. 11, pp. 1583-1595
Open Access | Times Cited: 14
Towards the convergent therapeutic potential of G protein‐coupled receptors in autism spectrum disorders
Anil Annamneedi, Caroline Gora, Ana Dudas, et al.
British Journal of Pharmacology (2023)
Open Access | Times Cited: 14
Optimal dose of oxytocin to improve social impairments and repetitive behaviors in autism spectrum disorders: meta-analysis and dose–response meta-analysis of randomized controlled trials
Yingying Zhang, Xiaolu Zhang, Linghong Huang
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Oxytocin’s social and stress-regulatory effects in children with autism and intellectual disability: a protocol for a randomized placebo-controlled trial
G. Ricchiuti, A. Taillieu, E. Tuerlinckx, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Oxytocin and autism: Insights from clinical trials and animal models
Chuan Xing, Xiang Yu
Current Opinion in Neurobiology (2025) Vol. 92, pp. 103015-103015
Closed Access
Random forest and Shapley Additive exPlanations predict oxytocin targeted effects on brain functional networks involved in salience and sensorimotor processing, in a randomized clinical trial in autism
Elissar Andari, Kaundinya Gopinath, Erin N. O’Leary, et al.
Neuropsychopharmacology (2025)
Open Access
At the Head and Heart of Oxytocin’s Stress-Regulatory Neural and Cardiac Effects: A Chronic Administration RCT in Children with Autism
Kaat Alaerts, Nicky Daniëls, Matthijs Moerkerke, et al.
Psychotherapy and Psychosomatics (2023) Vol. 92, Iss. 5, pp. 315-328
Open Access | Times Cited: 9
Chronic oxytocin improves neural decoupling at rest in children with autism: an exploratory RCT
Kaat Alaerts, Matthijs Moerkerke, Nicky Daniëls, et al.
Journal of Child Psychology and Psychiatry (2024) Vol. 65, Iss. 10, pp. 1311-1326
Closed Access | Times Cited: 3
Intranasal oxytocin as a treatment for anxiety and autism: From subclinical to clinical applications
Hailian Yin, Meiyun Jiang, Tao Han, et al.
Peptides (2024) Vol. 176, pp. 171211-171211
Closed Access | Times Cited: 3
Disorders of puberty and neurodevelopment: A shared etiology?
Jordan E. Read, Alexandru Vasile‐Tudorache, Angel Newsome, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1541, Iss. 1, pp. 83-99
Open Access | Times Cited: 2
Towards a comprehensive approach to mentalization-based treatment for children with autism: integrating attachment, neurosciences, and mentalizing
Stefanella Costa‐Cordella, Patricia Soto‐Icaza, Karin Borgeaud, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndrome
Alyssa Josselsohn, Yin Zhao, Daniel Espinoza, et al.
Pharmacology & Therapeutics (2024), pp. 108734-108734
Closed Access | Times Cited: 1
Intranasal Oxytocin for Patients With Autism Spectrum Disorder: A Comprehensive Meta-Analysis of Preclinical and Clinical Studies
Fakher Rahim, Nameer Hashim Qasim, Toguzbaeva Karlygash, et al.
Review Journal of Autism and Developmental Disorders (2024)
Closed Access | Times Cited: 1
A clustering approach identifies an Autism Spectrum Disorder subtype more responsive to chronic oxytocin treatment
Weihua Zhao, Jiao Le, Qi Liu, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Oxytocin in autism: Rethinking treatment and research through a neurodivergent perspective
Jenny Phan, Patrick Dwyer, Mahmoud Medhat Elsherif, et al.
Psychoneuroendocrinology (2024) Vol. 171, pp. 107220-107220
Closed Access | Times Cited: 1
Current Status of Psychopharmacological, Neuromodulation, and Oxytocin Treatments for Autism: Implications for Clinical Practice
Vicki Bitsika, Christopher F. Sharpley
Advances in Neurodevelopmental Disorders (2023) Vol. 8, Iss. 3, pp. 355-364
Open Access | Times Cited: 2
A clustering approach identifies an Autism Spectrum Disorder subtype more responsive to chronic oxytocin treatment
Keith M. Kendrick, Weihua Zhao, Jiao Le, et al.
Research Square (Research Square) (2024)
Open Access
Transcriptome analysis identifies an ASD-Like phenotype in oligodendrocytes and microglia from C58/J amygdala that is dependent on sex and sociability
George D. Dalton, Stephen K. Siecinski, Viktoriya D. Nikolova, et al.
Behavioral and Brain Functions (2024) Vol. 20, Iss. 1
Open Access
Could intranasal oxytocin enhance the effects of psychotherapy in individuals with mental disorders? A systematic review and meta-analysis
Valeska Pérez-Arqueros, Joaquim Soler, Carlos Schmidt, et al.
Psychoneuroendocrinology (2024) Vol. 171, pp. 107206-107206
Closed Access
Impact of chronic intranasal oxytocin administration on face expression processing in autistic children: a randomized controlled trial using fMRI
Matthijs Moerkerke, Nicky Daniëls, Stephanie Van der Donck, et al.
Molecular Autism (2024) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top